³ÉÈËÖ±²¥

Saturday, April 11, 2026

Tag: commercialization

UofL research projects land KYNETIC grants

The Kentucky Network for Innovation and Commercialization (KYNETIC) has selected eight applicants from its Cycle 6 for project funding. KYNETIC is a National Institutes of Health (NIH)...

UofL secures record-breaking $201.5 million in powerhouse year for research Funding...

The University of Louisville secured a record $201.5 million in the 2021 fiscal year to support groundbreaking research. That funding, an increase of more than...

UofL-born cell therapy startup completes $150 million IPO

A University of Louisville startup working to develop a therapy that could improve the lives of kidney transplant recipients and sufferers of severe autoimmune...

UofL student cancer tech startup wins inaugural innovation competition 

A University of Louisville student startup aimed at fighting cancer has won the inaugural CardStart innovation competition.  The startup is MAC-BIO, led by MD/PhD student...

UofL receives grant to launch COVID-19 tech accelerator University seeks ideas...

The University of Louisville has received $750,000 from the U.S. Economic Development Administration to launch a new program aimed at solving the long-term health,...

UofL heart technology goes head-to-head with other innovations in bracket competition

A University of Louisville technology that could give researchers a longer window to test new medicines on human tissue samples is going head-to-head with...

UofL researcher uses fruit for less toxic drug delivery Suite of...

UofL researchers have found a less toxic way to deliver medicines by using the natural lipids in plants, particularly grapefruit and ginger. The resulting intellectual...

UofL secures $170 million in record-breaking year for research Funding from...

The University of Louisville secured nearly $170 million to support groundbreaking research in the 2019-2020 fiscal year — the university’s most successful year ever...

UofL-born cell therapy for organ transplants enters Phase 3 trial First...

A cell therapy born at the University of Louisville that could improve the lives of kidney transplant recipients has entered its Phase 3 clinical...

UofL-born technology for treating Type 1 diabetes has commercial partner

A University of Louisville-born therapy that helps people with Type 1 diabetes stay off immunosuppressants by re-educating the body’s immune system to accept transplanted...